| Product Information |
DR-XY45886_PI_01.pdf
|
| Registration Number |
DR-XY45886
|
| Generic Name |
Dolutegravir (as Sodium)
|
| Brand Name |
Tivicay
|
| Dosage Strength |
50 mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription (RX) Drug
|
| Pharmacologic Category |
-
|
| Packaging |
HDPE Bottle with Child Resistant Closure x 30's (Box of 1 Bottle)
|
| Manufacturer |
Glaxo Operations UK Ltd
|
| Country of Origin |
United Kingdom
|
| Trader |
Viiv Healthcare UK Limited
|
| Importer |
Glaxo Wellcome S.A.
|
| Distributor |
Glaxo Wellcome S.A.
|
| Application Type |
Initial (from Monitored release)
|
| Issuance Date |
17 August 2023
|
| Expiry Date |
16 August 2027
|